US7129390B2
(en)
*
|
1997-10-16 |
2006-10-31 |
Avigenics, Inc |
Poultry Derived Glycosylated Interferon Alpha 2b
|
JP4087563B2
(ja)
*
|
1998-06-15 |
2008-05-21 |
ジーティーシー バイオセラピューティックス インコーポレイテッド |
エリスロポエチン類似体−ヒト血清アルブミン融合物
|
US20050181482A1
(en)
*
|
2004-02-12 |
2005-08-18 |
Meade Harry M. |
Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
|
US20030005468A1
(en)
*
|
1998-06-19 |
2003-01-02 |
Meade Harry M. |
Methods and vectors for improving nucleic acid expression
|
GB9817084D0
(en)
*
|
1998-08-06 |
1998-10-07 |
Wood Christopher B |
A method for promoting extra-heptic production of proteins for the correction of hypoalbuminaemia,anaemia,thrombocytopenia and/or coagulation disorders
|
US7304150B1
(en)
*
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
MXPA02002768A
(es)
*
|
1999-09-17 |
2002-08-30 |
Genzyme Transgenics Corp |
Proteinas de fusion optimizadas en sub-unidades.
|
CA2391080A1
(en)
*
|
1999-11-12 |
2001-05-25 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Erythropoietin forms with improved properties
|
AU2001259063A1
(en)
*
|
2000-04-12 |
2001-10-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US20040226053A1
(en)
*
|
2000-10-13 |
2004-11-11 |
Meade Harry M. |
Methods of producing a target molecule in a transgenic animal and purification of the target molecule
|
IL155812A0
(en)
*
|
2000-12-07 |
2003-12-23 |
Lilly Co Eli |
Glp-1 fusion proteins
|
PT1471871E
(pt)
|
2001-02-02 |
2007-06-05 |
Ortho Mcneil Pharm Inc |
Tratamento de disfunção neurológica compreendendo sulfamatos de frutopiranose e eritropoietina
|
US6992174B2
(en)
|
2001-03-30 |
2006-01-31 |
Emd Lexigen Research Center Corp. |
Reducing the immunogenicity of fusion proteins
|
WO2003030821A2
(en)
*
|
2001-10-05 |
2003-04-17 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US6818613B2
(en)
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
NZ532988A
(en)
|
2001-11-28 |
2008-04-30 |
Ortho Mcneil Pharm Inc |
Erythropoietin dosing regimen for treating anemia
|
WO2003059934A2
(en)
|
2001-12-21 |
2003-07-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
EP1463751B1
(en)
|
2001-12-21 |
2013-05-22 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US7129267B2
(en)
|
2002-03-11 |
2006-10-31 |
Janssen Pharmaceutica N.V. |
Methods for SHP1 mediated neuroprotection
|
EP1539960B1
(en)
*
|
2002-09-09 |
2010-04-28 |
Hanall Pharmaceutical Co., Ltd. |
Protease-resistant modified interferon alpha polypeptides
|
US7803362B2
(en)
*
|
2003-01-24 |
2010-09-28 |
Synageva Biopharma Corp. |
Glycosylated interferon alpha
|
US20040198663A1
(en)
*
|
2003-04-04 |
2004-10-07 |
Baker John E. |
Method of treating cardiac ischemia by using erythropoietin
|
WO2004101620A2
(en)
*
|
2003-05-01 |
2004-11-25 |
Compound Therapeutics, Inc. |
Serum albumin scaffold-based proteins and uses thereof
|
EP1729795B1
(en)
|
2004-02-09 |
2016-02-03 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US7588745B2
(en)
*
|
2004-04-13 |
2009-09-15 |
Si Options, Llc |
Silicon-containing products
|
CA2577786A1
(en)
*
|
2004-09-03 |
2006-03-16 |
Alza Corporation |
Endogenously-formed conjugate of albumin
|
CA2634495A1
(en)
*
|
2005-12-22 |
2007-06-28 |
Conjuchem Biotechnologies Inc. |
Process for the production of preformed conjugates of albumin and a therapeutic agent
|
US7625564B2
(en)
*
|
2006-01-27 |
2009-12-01 |
Novagen Holding Corporation |
Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
|
EP1816201A1
(en)
|
2006-02-06 |
2007-08-08 |
CSL Behring GmbH |
Modified coagulation factor VIIa with extended half-life
|
US7812127B2
(en)
|
2006-03-17 |
2010-10-12 |
Synageva Biopharma Corp. |
Glycosylated human G-CSF
|
PL2007885T3
(pl)
*
|
2006-04-11 |
2010-12-31 |
Csl Behring Gmbh |
Sposób zwiększania odzysku peptydów terapeutycznych in vivo
|
CN101062407A
(zh)
|
2006-04-29 |
2007-10-31 |
中国科学院上海生命科学研究院 |
促红细胞生成素在预防或治疗视网膜损伤中的用途
|
EP2046367A4
(en)
|
2006-06-07 |
2009-11-11 |
Human Genome Sciences Inc |
ALBUM INFUSION PROTEINS
|
US7939632B2
(en)
*
|
2006-06-14 |
2011-05-10 |
Csl Behring Gmbh |
Proteolytically cleavable fusion proteins with high molar specific activity
|
EP2069396B1
(en)
|
2006-09-08 |
2015-10-21 |
Ambrx, Inc. |
Modified human plasma polypeptide or fc scaffolds and their uses
|
EP2076530A4
(en)
*
|
2006-11-09 |
2010-04-07 |
Synageva Biopharma Corp |
ERYTHROPOIETIN OBTAINED FROM BIRDS
|
US20090105462A1
(en)
*
|
2006-11-09 |
2009-04-23 |
Ivarie Robert D |
Glycosylated erythropoietin
|
WO2008056961A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Boryung Pharmaceutical Co., Ltd |
A novel fusion protein, cell lines expressing the same and preparation method thereof
|
EP2120998B1
(en)
|
2006-11-28 |
2013-08-07 |
HanAll Biopharma Co., Ltd. |
Modified erythropoietin polypeptides and uses thereof for treatment
|
WO2008077616A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Csl Behring Gmbh |
Modified coagulation factors with prolonged in vivo half-life
|
PE20130588A1
(es)
|
2007-02-02 |
2013-05-21 |
Amgen Inc |
Hepcidina, antagonistas de la hepcidina y metodos de uso
|
BRPI0814465B1
(pt)
|
2007-07-26 |
2021-11-23 |
Novagen Holding Corporation |
Proteína de fusão, dímero, método para produzir uma proteína de fusão, linhagem de célula, usos de uma proteína de fusão e de uma composição farmacêutica e composição farmacêutica
|
EP2176414A4
(en)
*
|
2007-08-08 |
2011-01-26 |
Cho A Pharm Co Ltd |
EXPRESSION VECTOR FOR BREAST-DRY SPECIFIC HUMAN ERYTHROPOIETIN, TRANSGENIC ANIMAL AND METHOD FOR THE PRODUCTION OF HUMAN ERYTHROPOIETIN USING THEREOF
|
ES2750254T3
(es)
|
2007-09-27 |
2020-03-25 |
Amgen Inc |
Formulaciones farmacéuticas
|
EP2219602A1
(en)
|
2007-11-15 |
2010-08-25 |
Amgen, Inc |
Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
|
KR101343485B1
(ko)
*
|
2008-01-07 |
2013-12-20 |
시나게바 바이오파르마, 코포레이션 |
조류에서의 당화
|
EP2803675A3
(en)
|
2008-01-25 |
2014-12-24 |
Amgen, Inc |
Ferroportin antibodies and methods of use
|
SG188143A1
(en)
|
2008-02-08 |
2013-03-28 |
Ambrx Inc |
Modified leptin polypeptides and their uses
|
AU2009246946B2
(en)
|
2008-05-01 |
2013-09-26 |
Amgen Inc. |
Anti-hepcidin antibodies and methods of use
|
WO2010002082A1
(en)
*
|
2008-06-30 |
2010-01-07 |
Cho-A Pharm Co., Ltd. |
A gene of porcine beta-casein, a promoter of the same and the use thereof
|
AU2009266603B2
(en)
*
|
2008-06-30 |
2013-01-24 |
Cho-A Pharm Co., Ltd. |
Gene of porcine alpha-s1 casein, a promoter of the same and use thereof
|
PL2342223T3
(pl)
|
2008-09-26 |
2017-09-29 |
Ambrx, Inc. |
Zmodyfikowane polipeptydy zwierzęcej erytropoetyny i ich zastosowania
|
US8318167B2
(en)
|
2008-11-13 |
2012-11-27 |
The General Hospital Corporation |
Methods and compositions for regulating iron homeostasis by modulation of BMP-6
|
WO2010138184A2
(en)
*
|
2009-05-27 |
2010-12-02 |
Synageva Biopharma Corp. |
Avian derived antibodies
|
WO2011050333A1
(en)
|
2009-10-23 |
2011-04-28 |
Amgen Inc. |
Vial adapter and system
|
EP2502939B1
(en)
|
2009-11-19 |
2016-01-27 |
Zhejiang University |
Nonnatural collagen-like protein and use thereof
|
FI2575935T4
(fi)
|
2010-06-07 |
2023-11-23 |
Amgen Inc |
Lääkeaineen vapautuslaite
|
EP2598527A4
(en)
|
2010-07-28 |
2014-01-08 |
Smartcells Inc |
RECOMBINANT EXPRESSED INSULIN POLYPEPTIDES AND APPLICATIONS THEREOF
|
KR20140093603A
(ko)
|
2010-12-30 |
2014-07-28 |
라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 |
병원체 불활성화제로서의 글리콜
|
EP2691065B1
(en)
|
2011-03-31 |
2017-03-01 |
Amgen Inc. |
Vial adapter and system
|
CA2833748C
(en)
|
2011-04-20 |
2019-07-16 |
Amgen Inc. |
Autoinjector apparatus
|
AR087433A1
(es)
*
|
2011-08-08 |
2014-03-26 |
Merck Sharp & Dohme |
Analogos de insulina n-glicosilados
|
BR112014008993B1
(pt)
|
2011-10-14 |
2021-06-08 |
Amgen Inc |
injetor e método de montagem
|
CA2884887C
(en)
|
2012-11-21 |
2023-09-12 |
Amgen Inc. |
Drug delivery device including insertion member and reservoir
|
AR094778A1
(es)
|
2013-02-13 |
2015-08-26 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
Proteínas con glicosilación modificada y métodos para producirlas
|
KR20160002713A
(ko)
|
2013-02-13 |
2016-01-08 |
라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 |
고도로 갈락토실화된 항-tnf-알파 항체 및 이의 용도
|
WO2014124487A1
(en)
|
2013-02-18 |
2014-08-21 |
Vegenics Pty Limited |
Ligand binding molecules and uses thereof
|
JP6336564B2
(ja)
|
2013-03-15 |
2018-06-06 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入器、および自動注入器システム
|
CN105263514B
(zh)
|
2013-03-15 |
2019-04-26 |
本质生命科学有限公司 |
抗铁调素抗体及其用途
|
TWI580452B
(zh)
|
2013-03-15 |
2017-05-01 |
安美基公司 |
用於注射器之匣盒、注射器及使用包括自動注射器及匣盒之設備之方法
|
SG11201507878SA
(en)
|
2013-03-22 |
2015-10-29 |
Amgen Inc |
Injector and method of assembly
|
JP2016532100A
(ja)
|
2013-07-05 |
2016-10-13 |
ラボラトワール・フランセ・デュ・フラクシオンマン・エ・デ・ビョテクノロジーLaboratoire Francais Du Fractionnement Et Des Biotechnologies |
アフィニティークロマトグラフィーマトリックス
|
EP3060281B1
(en)
|
2013-10-24 |
2019-01-30 |
Amgen Inc. |
Drug delivery system with temperature-sensitive control
|
WO2015061386A1
(en)
|
2013-10-24 |
2015-04-30 |
Amgen Inc. |
Injector and method of assembly
|
US10994112B2
(en)
|
2014-02-05 |
2021-05-04 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
EP3785749A1
(en)
|
2014-05-07 |
2021-03-03 |
Amgen Inc. |
Autoinjector with shock reducing elements
|
WO2015187797A1
(en)
|
2014-06-03 |
2015-12-10 |
Amgen Inc. |
Controllable drug delivery system and method of use
|
CA2961917A1
(en)
|
2014-09-22 |
2016-03-31 |
Intrinsic Lifesciences Llc |
Humanized anti-hepcidin antibodies and uses thereof
|
US10695506B2
(en)
|
2014-10-14 |
2020-06-30 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
ES2898469T3
(es)
|
2014-12-19 |
2022-03-07 |
Amgen Inc |
Dispositivo de administración de medicamentos con sensor de proximidad
|
EP3689394A1
(en)
|
2014-12-19 |
2020-08-05 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
WO2016133947A1
(en)
|
2015-02-17 |
2016-08-25 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
WO2016138434A1
(en)
|
2015-02-27 |
2016-09-01 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
JP6959229B2
(ja)
*
|
2015-10-23 |
2021-11-02 |
アポジェニックス アーゲー |
一本鎖gitr受容体アゴニストタンパク質
|
JP7082568B2
(ja)
|
2015-12-09 |
2022-06-08 |
アムジエン・インコーポレーテツド |
信号伝達キャップ付き自動注射器
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
ES2814287T3
(es)
|
2016-03-15 |
2021-03-26 |
Amgen Inc |
Reducir la probabilidad de rotura de cristal en dispositivos de administración de fármaco
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
EP3455142B1
(en)
|
2016-05-13 |
2023-08-09 |
Amgen Inc. |
Vial sleeve assembly
|
EP3458988B1
(en)
|
2016-05-16 |
2023-10-18 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
EP3478342A1
(en)
|
2016-07-01 |
2019-05-08 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
AU2018210301A1
(en)
|
2017-01-17 |
2019-08-01 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
MX2019009625A
(es)
|
2017-02-17 |
2019-10-09 |
Amgen Inc |
Dispositivo de administracion de farmacos con trayectoria de flujo de fluido esteril y metodo relacionado de ensamblaje.
|
JP7280189B2
(ja)
|
2017-02-17 |
2023-05-23 |
アムジエン・インコーポレーテツド |
薬物送達装置用の挿入機構
|
MX2019010544A
(es)
|
2017-03-06 |
2019-10-21 |
Amgen Inc |
Dispositivo de administracion de farmacos con caracteristica de prevencion de la activacion.
|
SG11201908058UA
(en)
|
2017-03-07 |
2019-09-27 |
Amgen Inc |
Needle insertion by overpressure
|
MX2019010671A
(es)
|
2017-03-09 |
2019-10-21 |
Amgen Inc |
Mecanismo de insercion para dispositivo de administracion de farmacos.
|
WO2018172219A1
(en)
|
2017-03-20 |
2018-09-27 |
F. Hoffmann-La Roche Ag |
Method for in vitro glycoengineering of an erythropoiesis stimulating protein
|
EP3600491B1
(en)
|
2017-03-28 |
2023-08-09 |
Amgen Inc. |
Plunger rod and syringe assembly system and method
|
AU2018280054B2
(en)
|
2017-06-08 |
2023-07-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
MX2019014615A
(es)
|
2017-06-08 |
2020-02-07 |
Amgen Inc |
Dispositivo de administracion de farmacos accionado por par de torsion.
|
JP7195276B2
(ja)
|
2017-06-22 |
2022-12-23 |
アムジエン・インコーポレーテツド |
デバイス起動による衝突/衝撃の低減
|
WO2018237225A1
(en)
|
2017-06-23 |
2018-12-27 |
Amgen Inc. |
ELECTRONIC DRUG DELIVERY DEVICE COMPRISING A CAP ACTIVATED BY A SWITCH ASSEMBLY
|
ES2972207T3
(es)
|
2017-07-14 |
2024-06-11 |
Amgen Inc |
Sistema de inserción-retracción de agujas con sistema de resorte de torsión doble
|
IL271173B2
(en)
|
2017-07-21 |
2024-04-01 |
Amgen Inc |
Gas permeable sealing element for drug container and methods of assembly
|
JP7242562B2
(ja)
|
2017-07-25 |
2023-03-20 |
アムジエン・インコーポレーテツド |
容器アクセスシステムを有する薬物送達デバイス及び関連する組立方法
|
MA49677A
(fr)
|
2017-07-25 |
2021-04-21 |
Amgen Inc |
Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé
|
EP3664863A2
(en)
|
2017-08-09 |
2020-06-17 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
EP3668567A1
(en)
|
2017-08-18 |
2020-06-24 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
US11759565B2
(en)
|
2017-10-04 |
2023-09-19 |
Amgen Inc. |
Flow adapter for drug delivery device
|
EP3691716B1
(en)
|
2017-10-06 |
2023-11-29 |
Amgen Inc. |
Drug delivery device with interlock assembly and related method of assembly
|
WO2019074579A1
(en)
|
2017-10-09 |
2019-04-18 |
Amgen Inc. |
DRUG DELIVERY DEVICE COMPRISING A DRIVE ASSEMBLY AND ASSEMBLY METHOD THEREOF
|
EP3703779A1
(en)
|
2017-11-03 |
2020-09-09 |
Amgen Inc. |
Systems and approaches for sterilizing a drug delivery device
|
JP2021501616A
(ja)
|
2017-11-06 |
2021-01-21 |
アムジエン・インコーポレーテツド |
配置及び流量検出を備える薬物送達デバイス
|
WO2019090303A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
CN116832271A
(zh)
|
2017-11-10 |
2023-10-03 |
安进公司 |
用于药物递送装置的柱塞
|
EP3710089A1
(en)
|
2017-11-16 |
2020-09-23 |
Amgen Inc. |
Autoinjector with stall and end point detection
|
AU2018368340B2
(en)
|
2017-11-16 |
2024-03-07 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
US20210260279A1
(en)
|
2018-07-24 |
2021-08-26 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
MX2021000748A
(es)
|
2018-07-24 |
2021-03-26 |
Amgen Inc |
Dispositivos de suministro para administrar farmacos.
|
EP3826699A1
(en)
|
2018-07-24 |
2021-06-02 |
Amgen Inc. |
Delivery devices for administering drugs
|
CA3103105A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
CA3106452A1
(en)
|
2018-09-24 |
2020-04-02 |
Amgen Inc. |
Interventional dosing systems and methods
|
IL281469B1
(en)
|
2018-09-28 |
2024-04-01 |
Amgen Inc |
Assembling a memory alloy ejector activation assembly for a drug delivery device
|
TW202027806A
(zh)
|
2018-10-02 |
2020-08-01 |
美商安進公司 |
具有內部力傳遞的用於藥物遞送之注射系統
|
AR116607A1
(es)
|
2018-10-05 |
2021-05-26 |
Amgen Inc |
Dispositivo de administración de fármacos con indicador de dosis
|
MA53913A
(fr)
|
2018-10-15 |
2022-01-19 |
Amgen Inc |
Procédé d'assemblage de plate-forme pour dispositif d'administration de médicament
|
CN112789073B
(zh)
|
2018-10-15 |
2023-09-15 |
安进公司 |
具有阻尼机构的药物递送装置
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
WO2020091956A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
US20220031939A1
(en)
|
2018-11-01 |
2022-02-03 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
JP7510952B2
(ja)
|
2019-04-24 |
2024-07-04 |
アムジエン・インコーポレーテツド |
シリンジ滅菌確認アセンブリ及び方法
|
JP2022545227A
(ja)
|
2019-08-23 |
2022-10-26 |
アムジエン・インコーポレーテツド |
構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法
|
US10894812B1
(en)
|
2020-09-30 |
2021-01-19 |
Alpine Roads, Inc. |
Recombinant milk proteins
|
US10947552B1
(en)
|
2020-09-30 |
2021-03-16 |
Alpine Roads, Inc. |
Recombinant fusion proteins for producing milk proteins in plants
|
EP4222167A1
(en)
|
2020-09-30 |
2023-08-09 |
Nobell Foods, Inc. |
Recombinant milk proteins and food compositions comprising the same
|
KR20240011135A
(ko)
|
2021-05-21 |
2024-01-25 |
암젠 인크 |
약물 용기를 위한 충전 레시피를 최적화하는 방법
|
WO2024094457A1
(en)
|
2022-11-02 |
2024-05-10 |
F. Hoffmann-La Roche Ag |
Method for producing glycoprotein compositions
|